z-logo
open-access-imgOpen Access
Evaluation of Receptor Activator of Nuclear Factor Kappa-B Ligand and Osteoprotegerin Levels in Patients with Type 2 Diabetes Mellitus Treated with Oral Anti-diabetics (Sulfonylurea and Metformin) or Insulin: Bone Tissue Perspective
Author(s) -
Alper Gümüş,
Muhammed Emin Düz,
Cihan Coşkun,
Mustafa Velet,
Macit Koldaş
Publication year - 2019
Publication title -
i̇stanbul medical journal
Language(s) - English
Resource type - Journals
ISSN - 2619-9793
DOI - 10.4274/imj.galenos.2018.04657
Subject(s) - osteoprotegerin , metformin , medicine , endocrinology , sulfonylurea , diabetes mellitus , activator (genetics) , type 2 diabetes mellitus , insulin , receptor

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom